Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Delayed speech and language development, Mild intellectual disability, Global developmental delay, and Sleep disturbance and others; and common findings: Febrile seizure (within the age range of 3 months to 6 years), Dysarthria, Diminished ability to concentrate, and Plagiocephaly and others.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 6 | Delayed speech and language development, Mild intellectual disability, Febrile seizure (within the age range of 3 months to 6 years) |
EMC10 encodes ER membrane protein complex subunit 10 (262 aa). Part of the endoplasmic reticulum membrane protein complex (EMC) that enables the energy-independent insertion into endoplasmic reticulum membranes of newly synthesized membrane proteins. Highest expression in Thyroid (72.4 TPM) and Pituitary (67.5 TPM).
Neurodevelopmental disorder with dysmorphic facies and variable seizures is associated with mutations in the EMC10 gene on chromosome 19.
EMC10 is classified as a druggable target (Druggable Genome category) with score 0.0.
EMC10-related neurodevelopmental disorder (EMC10-NDD) should be considered in probands with the following clinical and imaging findings and family history:
Clinical findings
Moderate-to-severe developmental delay
Mild-to-severe intellectual disability
No approved treatments are currently available for neurodevelopmental disorder with dysmorphic facies and variable seizures. The disease remains an area of unmet medical need.
No clinical practice guidelines for EMC10-related neurodevelopmental disorder (EMC10-NDD) have been published. Evaluations Following Initial Diagnosis To establish the extent of disease and needs in an individual diagnosed with EMC10-NDD, the evaluations summarized (if not performed as part of the evaluation that led to the diagnosis) are recommended. Table 3. EMC10-Related Neurodevelopmental Disorder: Recommended Evaluations Following Initial Diagnosis
To monitor existing manifestations, the individual's response to supportive care, and the emergence of new manifestations, the evaluations summarized in are recommended. Table 5. EMC10-Related Neurodevelopmental Disorder: Recommended Surveillance
No clinical trials have been registered for neurodevelopmental disorder with dysmorphic facies and variable seizures.
10 publications have been identified in PubMed for neurodevelopmental disorder with dysmorphic facies and variable seizures. Research spans Case Report / Case Series (70%), Review / Meta-Analysis (10%), and Basic Science / Preclinical (10%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 7 | 70% |
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 4:31 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Eyes | 1 | Nystagmus |
Pregnancy and birth | 1 | Fetal distress |
Head and neck | 1 | Triangular face |
EMC10-related neurodevelopmental disorder (EMC10-NDD) is characterized by developmental delay, intellectual disability, and dysmorphic features (long face, pointed chin, nystagmus, crowded teeth). Neurobehavioral manifestations, seizures, growth deficiency, and microcephaly have been reported in some individuals. To date, 30 individuals have been identified with biallelic pathogenic variants in EMC10 [, , , ]. The following description of the phenotypic features associated with this condition is based on these reports. Table 2. EMC10-Related Neurodevelopmental Disorder: Frequency of Select Features
Feature | Proportion of Persons w/Feature | Comment |
|---|---|---|
Developmental delay | 29/30 | Moderate to severe |
Intellectual disability | 29/30 | Mild to severe |
Seizures | 13/30 | — |
Poor weight gain/ growth deficiency | 9/30 | — |
Microcephaly | 4/30 | — |
Nephrocalcinosis | 4/30 | — |
Renal cysts | 5/30 | — |
Hydronephrosis/hydroureter | 3/30 | — |
Dysmorphic facial features | 30/30 | Long face, pointed chin, nystagmus, crowded teeth Developmental delay. Most individuals with EMC10-NDD present with developmental delay affecting motor, speech, and cognition. Developmental delays are variable, with disability ranging from moderate to severe. |
Source: GeneReviews — "EMC10-Related Neurodevelopmental Disorder"
No genotype-phenotype correlations have been identified.
Source: GeneReviews — "EMC10-Related Neurodevelopmental Disorder"
Seizures: multifocal, generalized tonic–clonic, and/or febrile
Poor weight gain and growth deficiency
Microcephaly (in some individuals)
Upper limb anomalies: cubitus valgus, arachnodactyly, and fifth finger clinodactyly
Source: GeneReviews — "EMC10-Related Neurodevelopmental Disorder"
The phenotypic features associated with EMC10-related neurodevelopmental disorder are not sufficient to diagnose this condition clinically; thus, all disorders with intellectual disability without other distinctive findings should be considered in the differential diagnosis. See OMIM Phenotypic Series for genes associated with:
• Autosomal dominant intellectual developmental disorders
• Autosomal recessive intellectual developmental disorders
• Syndromic X-linked intellectual developmental disorders
Source: GeneReviews — "EMC10-Related Neurodevelopmental Disorder"
Genetic testing for EMC10 is available. Testing is considered confirmatory for diagnosis.
System/Concern | Evaluation | Comment |
|---|---|---|
Development | Developmental assessment | To incl motor, adaptive, cognitive, speech-language eval; Eval for early intervention/ special education |
Musculoskeletal | Orthopedics/ physical medicine rehab/ PT OT eval | To incl assessment of:; Gross motor fine motor skills; Mobility, ADL, need for adaptive devices; Need for PT (to improve gross motor skills) /or OT (to improve fine motor skills) Neurobehavioral/ |
Psychiatric | Neuropsychiatric eval for behavior concerns incl ADHD impaired social skills | For persons age 12 mos |
Neurologic | Neurologic eval | To incl brain MRI if not performed at time of diagnosis; EEG if seizures are suspected Growth/Nutrition |
Urinary tract | Kidney urinary tract ultrasound | — |
Genetic counseling | By genetics professionals1 | To inform affected persons their families re nature, MOI, implications of EMC10-NDD to facilitate medical personal decision making Family support resources |
EMC10-Related Neurodevelopmental Disorder: Treatment of Manifestations Manifestation/Concern | Treatment | Considerations/Other Developmental delay/ Intellectual disability/ |
Behavioral manifestations | See . | — |
Epilepsy | Standardized treatment w/ASM by experienced neurologist | Many ASMs may be effective; none has been demonstrated effective specifically for this disorder.; Education of parents/caregivers1 Growth deficiency/ |
Poor weight gain | Nutritional support as needed | — |
Renal manifestations | Standard treatments per nephrologist | Family/Community |
Source: GeneReviews — "EMC10-Related Neurodevelopmental Disorder"
Search ClinicalTrials.gov in the US and EU Clinical Trials Register in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.
Source: GeneReviews — "EMC10-Related Neurodevelopmental Disorder"
View trials for neurodevelopmental disorder with dysmorphic facies and variable seizures
Evaluation |
|---|
Frequency |
|---|
Development | Assess developmental progress educational needs. | At each visit Musculoskeletal |
Renal | Follow-up labs imaging | Per nephrologist |
Family/Community | Assess family need for social work support (e.g., palliative/respite care, home nursing, other local resources), care coordination, or follow-up genetic counseling if new questions arise (e.g., family planning). | At each visit ADHD = attention-deficit/hyperactivity disorder; OT = occupational therapy; PT = physical therapy |
Source: GeneReviews — "EMC10-Related Neurodevelopmental Disorder"
Phenotype severity distribution: 13 always present features, 5 common features.
Research summaries |
1 |
10% |
Laboratory research | 1 | 10% |
New treatment approaches | 1 | 10% |
Abdel-Ghafar SF (2026). [PMID: 41025723](https://pubmed.ncbi.nlm.nih.gov/41025723/). *Clinical genetics*. [Case Report / Case Series]
Peter B (2026). [PMID: 40891523](https://pubmed.ncbi.nlm.nih.gov/40891523/). *American journal of medical genetics. Part A*. [Case Report / Case Series]
Abdel-Hamid MS (2026). [PMID: 41571908](https://pubmed.ncbi.nlm.nih.gov/41571908/). *Journal of human genetics*. [Basic Science / Preclinical]
Forest-St-Onge G (2025). [PMID: 40150819](https://pubmed.ncbi.nlm.nih.gov/40150819/). *Clinical genetics*. [Case Report / Case Series]
Rafat K (2025). [PMID: 40579404](https://pubmed.ncbi.nlm.nih.gov/40579404/). *Scientific reports*. [Case Report / Case Series]
Bolat H (2025). [PMID: 40741735](https://pubmed.ncbi.nlm.nih.gov/40741735/). *Developmental neurobiology*. [Case Report / Case Series]
Yeter B (2025). [PMID: 40742416](https://pubmed.ncbi.nlm.nih.gov/40742416/). *European journal of pediatrics*. [Case Report / Case Series]
Makio T (2024). [PMID: 39070058](https://pubmed.ncbi.nlm.nih.gov/39070058/). *Contact (Thousand Oaks (Ventura County, Calif.))*. [Review / Meta-Analysis]
Pan X (2024). [PMID: 38740982](https://pubmed.ncbi.nlm.nih.gov/38740982/). *Journal of human genetics*. [Gene Therapy / Novel Therapeutics]
Erdal İ (2024). [PMID: 38958169](https://pubmed.ncbi.nlm.nih.gov/38958169/). *Journal of pediatric endocrinology & metabolism : JPEM*. [Case Report / Case Series]